• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从 2009 年甲型 H1N1 流感大流行疫苗接种中吸取的教训。在布鲁塞尔举行的欧洲研讨会(2010 年 3 月 22 日)要点。

Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010).

机构信息

Health Care Knowledge Centre, Brussels, Belgium.

出版信息

Vaccine. 2011 Jan 10;29(3):370-7. doi: 10.1016/j.vaccine.2010.10.079. Epub 2010 Nov 12.

DOI:10.1016/j.vaccine.2010.10.079
PMID:21075164
Abstract

This European workshop identified a number of lessons learnt in the field of vaccine licensure, prioritization of target groups, communication on pandemic vaccines, implementation of vaccination and safety monitoring. The mild severity of the pandemic A(H1N1) 2009 influenza virus influenced the perception of pandemic vaccines, as previous pandemic preparedness had anticipated a more virulent virus. This vaccination experience provides an important opportunity for research on the long-term immunogenicity and safety of pandemic vaccines in pregnant women and children, as well as on the long-term safety of adjuvants. Preparedness for future pandemics could involve improved decision-making on target groups and increased communication on vaccine safety.

摘要

本次欧洲研讨会确定了疫苗许可、目标人群优先级划分、大流行疫苗沟通、疫苗接种实施和安全性监测等领域的一些经验教训。大流行流感病毒 A(H1N1)2009 的轻度严重程度影响了对大流行疫苗的看法,因为此前的大流行准备工作预计会出现更具毒性的病毒。这次接种疫苗的经验为研究大流行疫苗在孕妇和儿童中的长期免疫原性和安全性以及佐剂的长期安全性提供了重要机会。未来大流行的准备工作可能涉及改进目标人群的决策制定和加强疫苗安全性沟通。

相似文献

1
Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010).从 2009 年甲型 H1N1 流感大流行疫苗接种中吸取的教训。在布鲁塞尔举行的欧洲研讨会(2010 年 3 月 22 日)要点。
Vaccine. 2011 Jan 10;29(3):370-7. doi: 10.1016/j.vaccine.2010.10.079. Epub 2010 Nov 12.
2
Assessment of the immunogenicity and safety of varying doses of an MF59®-adjuvanted cell culture-derived A/H1N1 pandemic influenza vaccine in Japanese paediatric, adult and elderly subjects.评估 MF59®佐剂的细胞培养衍生 A/H1N1 大流行流感疫苗在日本儿科、成人和老年受试者中的免疫原性和安全性。
Vaccine. 2012 Jul 13;30(33):5030-7. doi: 10.1016/j.vaccine.2012.03.053. Epub 2012 Apr 1.
3
[Pandemic influenza A (H1N1)v vaccination status and factors affecting vaccination: Ankara and Diyarbakır 2009 data from Turkey].[甲型H1N1流感大流行疫苗接种状况及影响接种的因素:2009年来自土耳其安卡拉和迪亚巴克尔的数据]
Mikrobiyol Bul. 2011 Oct;45(4):684-96.
4
Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011.世界卫生组织 2011 年 2 月 17 日至 18 日在日内瓦举行的第七次临床试验中评估大流行性流感疫苗会议报告。
Vaccine. 2011 Oct 13;29(44):7579-86. doi: 10.1016/j.vaccine.2011.08.031. Epub 2011 Aug 19.
5
Safety and immunogenicity of an MF59-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age.MF59佐剂A/H1N1大流行性流感疫苗在3至17岁儿童中的安全性和免疫原性。
Vaccine. 2015 Jan 1;33(1):174-81. doi: 10.1016/j.vaccine.2014.10.085. Epub 2014 Nov 11.
6
Pandemic influenza vaccination during pregnancy: an investigation of vaccine uptake during the 2009/10 pandemic vaccination campaign in Great Britain.妊娠期流感疫苗接种:2009/10 年大不列颠流感大流行疫苗接种运动期间疫苗接种率的调查。
Hum Vaccin Immunother. 2013 Apr;9(4):917-23. doi: 10.4161/hv.23277. Epub 2013 Jan 30.
7
Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months.MF59 佐剂流感 A/H1N1 疫苗在 6 至 23 个月龄早产儿和足月儿中的应用。
Pediatrics. 2011 May;127(5):e1161-8. doi: 10.1542/peds.2010-1920. Epub 2011 Apr 4.
8
Uptake of influenza vaccine in pregnant women during the 2009 H1N1 influenza pandemic.孕妇在 2009 年 H1N1 流感大流行期间对流感疫苗的接种情况。
Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S112-5. doi: 10.1016/j.ajog.2011.01.007. Epub 2011 Feb 23.
9
Pandemic 2009-2010 influenza vaccine: six lessons learned and the way forward (Allegro not Adagio).2009 - 2010年大流行性流感疫苗:六点经验教训及未来方向(快板而非慢板)
Vaccine. 2011 Jan 17;29(4):613-4. doi: 10.1016/j.vaccine.2010.11.086.
10
New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain.新智慧应对老敌人:西班牙瓦伦西亚 2012 年第 4 届世界流感疫苗大会(IVW)科学研讨会摘要,2012 年 10 月 11 日。
Vaccine. 2013 Apr 17;31 Suppl 1:A1-20. doi: 10.1016/j.vaccine.2013.02.033.

引用本文的文献

1
Lessons learned from setting up a hospital-based national registry for venous thromboembolic disorders in India.在印度建立基于医院的静脉血栓栓塞症国家登记处的经验教训。
J Family Med Prim Care. 2024 Nov;13(11):4901-4909. doi: 10.4103/jfmpc.jfmpc_264_24. Epub 2024 Nov 18.
2
The long road of pandemic vaccine development to rollout: A systematic review on the lessons learnt from the 2009 H1N1 influenza pandemic.大流行疫苗研发到推出的漫漫长路:从 2009 年 H1N1 流感大流行中吸取的经验教训的系统评价。
Am J Infect Control. 2022 Jul;50(7):735-742. doi: 10.1016/j.ajic.2022.01.026. Epub 2022 Feb 4.
3
Delivering routine immunisations in London during the COVID-19 pandemic: lessons for future vaccine delivery. A mixed-methods study.
在新冠疫情期间于伦敦开展常规免疫接种:对未来疫苗接种工作的启示。一项混合方法研究。
BJGP Open. 2021 Aug 24;5(4). doi: 10.3399/BJGPO.2021.0021. Print 2021 Aug.
4
Constructing an ethical framework for priority allocation of pandemic vaccines.构建大流行疫苗优先分配的伦理框架。
Vaccine. 2021 Jan 29;39(5):797-804. doi: 10.1016/j.vaccine.2020.12.053. Epub 2021 Jan 3.
5
Listen to the public and fulfil their information interests - translating vaccine communication research findings into guidance for regulators.倾听公众意见并满足其信息需求——将疫苗传播研究结果转化为监管指南。
Br J Clin Pharmacol. 2018 Aug;84(8):1696-1705. doi: 10.1111/bcp.13587. Epub 2018 May 31.
6
Review on the effects of influenza vaccination during pregnancy on preterm births.孕期接种流感疫苗对早产影响的综述
Hum Vaccin Immunother. 2015;11(11):2538-48. doi: 10.1080/21645515.2015.1059976. Epub 2015 Aug 12.
7
Internet activity as a proxy for vaccination compliance.将互联网活动作为疫苗接种依从性的替代指标。
Vaccine. 2015 May 15;33(21):2395-8. doi: 10.1016/j.vaccine.2015.03.100. Epub 2015 Apr 11.
8
Willingness to Receive the Influenza A(H1N1) Vaccine and its Determinants among University Students during the 2009 Outbreak in Turkey.2009年土耳其疫情期间大学生接种甲型H1N1流感疫苗的意愿及其影响因素
Eurasian J Med. 2014 Feb;46(1):8-14. doi: 10.5152/eajm.2014.02.
9
Influenza A/H1N1 MF59 adjuvanted vaccine in pregnant women and adverse perinatal outcomes: multicentre study.甲型 H1N1 流感 MF59 佐剂疫苗在孕妇中的应用及不良围产期结局:多中心研究。
BMJ. 2013 Feb 4;346:f393. doi: 10.1136/bmj.f393.
10
Multi-centre observational study of transplacental transmission of influenza antibodies following vaccination with AS03(A)-adjuvanted H1N1 2009 vaccine.AS03(A)- 佐剂 H1N1 2009 疫苗接种后胎盘传播流感抗体的多中心观察性研究。
PLoS One. 2013;8(1):e47448. doi: 10.1371/journal.pone.0047448. Epub 2013 Jan 23.